Ingredient or product comparison
GHK-Cu Cosmetic Biomarkers: Efficacy Comparison
Type I Procollagen (COL1A1 expression) Collagen synthesis rate 1.5–2.0x baseline gene expression Rarely validated; no published data 70% increase at 5µM GHK-Cu (IJMS 2023) Gold standard for remodeling proof. Requires tissue analysis MMP-1 Inhibition Collagen d
This source-based comparison does not add ratings or recommend a winner.
- Type I Procollagen (COL1A1 expression)
- Collagen synthesis rate
- 1.5–2.0x baseline gene expression
- Rarely validated; no published data
- 70% increase at 5µM GHK-Cu (IJMS 2023)
- Gold standard for remodeling proof. Requires tissue analysis
- MMP-1 Inhibition
- Collagen degradation rate
- ≥40% reduction in enzyme activity
- Not measured in consumer testing
- 60% reduction at 1–5µM (Journal of Cosmetic Dermatology 2018)
- Direct anti-aging effect; requires zymography to quantify
- TGF-beta Upregulation
- Fibroblast activation signaling
- 1.3–1.8x baseline cytokine expression
- Not disclosed or measured
- 1.6x increase in aged fibroblasts (Experimental Gerontology 2020)
- Indicates cellular pathway activation. Not just surface effect
- Dermal Density (OCT imaging)
- Structural tissue thickness
- ≥10% increase over 12 weeks
- Subjective 'firmness' claims only
- 18% increase vs 3% placebo (RCT, 2019)
- Non-invasive surrogate; correlates with collagen content
- Elastin Fiber Density
- Elastic tissue remodeling
- Histological visualization required
- No consumer validation
- Increased fiber density in 12-week biopsy study
- Requires invasive biopsy. Not feasible for cosmetic marketing